z-logo
open-access-imgOpen Access
Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin
Author(s) -
Gloria S. Tannenbaum
Publication year - 1992
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.130.6.3395
Subject(s) - tamoxifen , endocrinology , medicine , somatostatin , estrogen , pulsatile flow , estrogen receptor , receptor , biology , breast cancer , cancer
Tamoxifen, a partial competitive anatgonist to the estrogen receptor, is a potent ainhibitor of the proliferation of experimental mammary carcinoma in the rat and is widely used clinically in the treatment of breast cancer.[...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom